A detailed history of Hanseatic Management Services Inc transactions in Castle Biosciences Inc stock. As of the latest transaction made, Hanseatic Management Services Inc holds 203 shares of CSTL stock, worth $4,047. This represents 0.01% of its overall portfolio holdings.

Number of Shares
203
Previous 203 -0.0%
Holding current value
$4,047
Previous $5,000 -0.0%
% of portfolio
0.01%
Previous 0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$17.4 - $31.47 $3,532 - $6,388
203 New
203 $5,000

Others Institutions Holding CSTL

About CASTLE BIOSCIENCES INC


  • Ticker CSTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 26,297,000
  • Market Cap $524M
  • Description
  • Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...
More about CSTL
Track This Portfolio

Track Hanseatic Management Services Inc Portfolio

Follow Hanseatic Management Services Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hanseatic Management Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Hanseatic Management Services Inc with notifications on news.